Met Life Investment Management, LLC Tricida, Inc. Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Jun 14, 2023	BUY	$8.51 - $13.6 $150,201 - $240,040	17,650 New	17,650 $184,000
Q2 2022 May 10, 2024	BUY	$7.31 - $11.85 $129,021 - $209,152	17,650 New	17,650 $170,000
Q2 2022 Jun 20, 2023	BUY	$7.31 - $11.85 $129,021 - $209,152	17,650 New	17,650 $170,000
Q2 2022 Mar 22, 2023	BUY	$7.31 - $11.85 $34,071 - $55,232	4,661 Added 35.88%	17,650 $170,000
Q2 2022 Aug 11, 2022	BUY	$7.31 - $11.85 $129,021 - $209,152	17,650 New	17,650 $171,000
Q4 2020 Feb 16, 2021	SELL	$4.37 - $9.46 $56,761 - $122,875	-12,989 Closed	0 $0
Q3 2020 Jun 26, 2023	BUY	$8.56 - $26.93 $111,185 - $349,793	12,989 New	12,989 $117,000
Q2 2020 May 24, 2024	BUY	$21.21 - $31.55 $275,496 - $409,802	12,989 New	12,989 $357 Million
Q2 2020 Jun 26, 2023	BUY	$21.21 - $31.55 $275,496 - $409,802	12,989 New	12,989 $356,000
Q2 2020 Mar 22, 2023	BUY	$21.21 - $31.55 $57,860 - $86,068	2,728 Added 26.59%	12,989 $356,000
Q2 2020 Aug 14, 2020	BUY	$21.21 - $31.55 $57,860 - $86,068	2,728 Added 26.59%	12,989 $357,000
Q1 2020 Jul 12, 2023	BUY	$18.43 - $38.04 $189,110 - $390,328	10,261 New	10,261 $225,000
Q4 2019 Jul 12, 2023	BUY	$29.6 - $43.71 $303,725 - $448,508	10,261 New	10,261 $387,000
Q3 2019 Jul 12, 2023	BUY	$29.87 - $42.22 $306,496 - $433,219	10,261 New	10,261 $316,000
Q3 2019 Mar 22, 2023	BUY	$29.87 - $42.22 $43,520 - $61,514	1,457 Added 16.55%	10,261 $316,000
Q3 2019 Nov 14, 2019	BUY	$29.87 - $42.22 $43,520 - $61,514	1,457 Added 16.55%	10,261 $317,000
Q2 2019 Jul 12, 2023	BUY	$31.16 - $39.46 $319,732 - $404,899	10,261 New	10,261 $404,000
Q1 2019 Jul 13, 2023	BUY	$19.96 - $38.62 $175,727 - $340,010	8,804 New	8,804 $340,000
Q1 2019 Mar 22, 2023	BUY	$19.96 - $38.62 $71,596 - $138,529	3,587 Added 68.76%	8,804 $340,000
Q1 2019 May 15, 2019	BUY	$19.96 - $38.62 $71,596 - $138,529	3,587 Added 68.76%	8,804 $340,000
Q4 2018 Jul 13, 2023	BUY	$23.57 - $32.33 $122,964 - $168,665	5,217 New	5,217 $123,000
Q4 2018 Mar 22, 2023	SELL	$23.57 - $32.33 $180,004 - $246,904	-7,637 Reduced 59.41%	5,217 $123,000
Q4 2018 Feb 14, 2019	SELL	$23.57 - $32.33 $180,004 - $246,904	-7,637 Reduced 59.41%	5,217 $123,000
Q3 2018 Jul 13, 2023	BUY	$22.5 - $39.35 $184,725 - $323,063	8,210 New	8,210 $250,000
Q3 2018 Mar 22, 2023	BUY	$22.5 - $39.35 $289,215 - $505,804	12,854 New	12,854 $392,000
Q3 2018 Nov 14, 2018	BUY	$22.5 - $39.35 $289,215 - $505,804	12,854 New	12,854 $393,000

Others Institutions Holding TCDA

# of Institutions

Shares Held

30K

Call Options Held

124K

Put Options Held

46.5K

View Full List

About Tricida, Inc.

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

More about TCDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account